Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Johnson

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcomeNicholas J Dickens, Brian A Walker, Paola E Leone, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2012
Altered fear learning across development in both mouse and humanSiobhan S Pattwell, Stéphanie Duhoux, Catherine A Hartley, et al.
European Urology|December 5, 2018
Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance ImagingDavid C Johnson, Steven S Raman, Sohrab A Mirak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myelomaDavid C Johnson, Sophie L Corthals, Brian A Walker, et al.
The Journal of Allergy and Clinical Immunology|April 15, 2011
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitisAnna De Benedetto, Mark K Slifka, Nicholas M Rafaels, et al.
Nature Communications|March 4, 2015
FAAH genetic variation enhances fronto-amygdala function in mouse and humanIva Dincheva, Andrew T Drysdale, Catherine A Hartley, et al.
Blood|August 23, 2017
Neutral tumor evolution in myeloma is associated with poor prognosisDavid C Johnson, Oleg Lenive, Jonathan Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Deletions of CDKN2C in multiple myeloma: biological and clinical implicationsPaola E Leone, Brian A Walker, Matthew W Jenner, et al.
The Journal of Urology|October 28, 2025
Impact of renal mass biopsy on decision-making experience for clinical T1 renal massesKathryn H Gessner, Allison M Deal, Amir Feinberg, et al.
Cancer|May 2, 2019
Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selectionDavid C Johnson, Jason J Yang, Lorna Kwan, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcomeNicholas J Dickens, Brian A Walker, Paola E Leone, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2012
Altered fear learning across development in both mouse and humanSiobhan S Pattwell, Stéphanie Duhoux, Catherine A Hartley, et al.
European Urology|December 5, 2018
Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance ImagingDavid C Johnson, Steven S Raman, Sohrab A Mirak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myelomaDavid C Johnson, Sophie L Corthals, Brian A Walker, et al.
The Journal of Allergy and Clinical Immunology|April 15, 2011
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitisAnna De Benedetto, Mark K Slifka, Nicholas M Rafaels, et al.
Nature Communications|March 4, 2015
FAAH genetic variation enhances fronto-amygdala function in mouse and humanIva Dincheva, Andrew T Drysdale, Catherine A Hartley, et al.
Blood|August 23, 2017
Neutral tumor evolution in myeloma is associated with poor prognosisDavid C Johnson, Oleg Lenive, Jonathan Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Deletions of CDKN2C in multiple myeloma: biological and clinical implicationsPaola E Leone, Brian A Walker, Matthew W Jenner, et al.
The Journal of Urology|October 28, 2025
Impact of renal mass biopsy on decision-making experience for clinical T1 renal massesKathryn H Gessner, Allison M Deal, Amir Feinberg, et al.
Cancer|May 2, 2019
Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selectionDavid C Johnson, Jason J Yang, Lorna Kwan, et al.
Pageof 25